Government Initiatives Boost Growth In Prenatal And Newborn Genetic Testing Market: Key Factor Driving The Growth In The Prenatal And Newborn Genetic Testing Market

The Prenatal And Newborn Genetic Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Prenatal And Newborn Genetic Testing Market Size During the Forecast Period?
The market size of prenatal and newborn genetic testing has experienced swift expansion in the past few years. Its growth is expected to surge from $6.68 billion in 2024 to $7.61 billion in 2025, with a compound annual growth rate (CAGR) of 13.9%. The notable growth during the historic period is chiefly due to advancements in non-invasive prenatal tests, the rise in the age of mothers, governmental aid and healthcare regulations, and the patients' need for early detection.

In the coming years, the market size for prenatal and newborn genetic testing is projected to witness significant growth, reaching $12.04 billion in 2029 with a 12.1% compound annual growth rate (CAGR). The expansion of genetic test panels, greater maternal health consciousness, guidelines for prenatal and newborn screening, increased focus on rare diseases, and moral and regulatory considerations are factors contributing to this anticipated growth. Key trends for this period are non-invasive prenatal testing (NIPT), whole genome sequencing (WGS) and whole exome sequencing, utilisation of artificial intelligence (AI), preimplantation genetic testing (PGT), and direct-to-consumer genetic testing.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13158

What Are the High-Growth Segments in the Prenatal And Newborn Genetic Testing Market?
The prenatal and newborn genetic testing market covered in this report is segmented -

1) By Product Type: Consumables, Instruments
2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings
3) By Disease: Down Syndrome, ket*onuria, Cystic Fibrosis, Sickle Cell Anemia
4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers

Subsegments:
1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp

What Key Drivers Are Expected to Influence Future Prenatal And Newborn Genetic Testing Market Growth?
Actions and support from government institutions aiming at furthering prenatal tests and newborn genetic screenings are anticipated to fuel the expansion of the prenatal and newborn genetic testing markets. These government initiatives encompass specific undertakings, programs, rules, or projects enacted by a government on a local, regional, or national scale with the objective of tackling specific issues, fulfilling particular objectives, or fostering the welfare of their society. The government's backing for prenatal and newborn genetic testing augments the wellbeing of a nation's population by assisting in the identification of genetic anomalies in unborn babies during pregnancy or soon after birth. For instance, the Australian government in June 2022, designated $1.3 million annually to the New South Wales newborn screening program to administer free tests for severe combined immunodeficiency and spinal muscular atrophy, incorporating newborn genetic testing and screening, to all newborns in the region. Roughly 100,000 babies are scheduled to receive these tests yearly, safeguarding up to 13 newborns that would likely suffer from these genetic diseases. Hence, governmental initiatives and support for prenatal testing and newborn genetic screening are driving the prenatal and newborn genetic testing markets. Driver for Prenatal And Newborn Genetic Testing Market: Increasing rates of genetic disorders push growth in the Prenatal And Newborn Genetic Testing Market

Which Companies Hold the Largest Share Across Different Prenatal And Newborn Genetic Testing Market Segments?
Major companies operating in the prenatal and newborn genetic testing market report are F. Hoffmann-La Roche AG, Novartis AG, Sanofi S.A., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton, Dickinson and Company, Quest Diagnostic Incorporated, Agilent Technologies Inc., Grifols S.A., Terumo Corporation, Illumina Inc., PerkinElmer Genomics, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen NV, Werfen S.A., DiaSorin S.p.A, Nova Biomedical, BGI Group, Natera Inc., Trinity Biotech PLC, Meridian Bioscience Inc., Sekisui Diagnostics, Chembio Diagnostics, PTS Diagnostics, Ariosa Diagnostics Inc., AccuBioTech Co. Ltd., Sequenom Inc.

What Trends Are Driving Growth in The Prenatal And Newborn Genetic Testing Market?
Leading enterprises in the newborn and prenatal genetic testing markets are concentrating on creating original diagnostic tests like noninvasive prenatal screening tests. These innovative technologies are being designed with a significant focus on increasing affordability and accessibility while delivering dependable services to consumers. Noninvasive prenatal screening (NIPS), also known as noninvasive prenatal testing (NIPT), is a cutting-edge, safe genetic screening technique used during pregnancy to evaluate the possibility of certain fetal chromosomal anomalies. For example, in November 2022, Juno Diagnostics Inc., a medical technology firm based in America, introduced Juno Hazel. This noninvasive prenatal screening test identifies chromosomal irregularities while providing meaningful clinical data. The system incorporates a sample collection kit that removes the need for phlebotomy, hence augmenting accessibility. To extend personalized genetic counseling support and educational resources, the company is strategizing partnerships with genetic counselors and physicians.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/prenatal-and-newborn-genetic-testing-global-market-report

What Are the Emerging Geographies for The Prenatal And Newborn Genetic Testing Market Growth?
North America was the largest region in the prenatal and newborn genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Prenatal And Newborn Genetic Testing Market?
2. What is the CAGR expected in the Prenatal And Newborn Genetic Testing Market?
3. What Are the Key Innovations Transforming the Prenatal And Newborn Genetic Testing Industry?
4. Which Region Is Leading the Prenatal And Newborn Genetic Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.